Dosing and uses of Sulfanilamide (AVC)
Adult dosage forms and strengths
vaginal cream
- 15%
Candida Vulvovaginitis
1 applicator (~6 g) intravaginal qD-BID x30 days
Pediatric dosage forms and strengths
N/A
Sulfanilamide (AVC) adverse (side) effects
Frequency not defined
Local sensitivity reactions
Warnings
Contraindications
Hypersensitivity to sulfonamides
Cautions
Third trimester of pregnancy
Discontinue if skin rash
Pregnancy and lactation
Pregnancy category: C
Lactation: avoid
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of Sulfanilamide (AVC)
Absorption: yes
Mechanism of action
Sulfa drug
